Mexoryl 400: The Ultra-Long UVA Filter Closing Sunscreen's Biggest Gap

Sunscreen labeling tells consumers what SPF blocks UVB and what "broad spectrum" means at a regulatory minimum, but neither metric describes performance past 380nm. The 380–400nm band, called ultra-long UVA, drives a documented share of photoaging, persistent pigment darkening, and mitochondrial damage in dermal fibroblasts. Most conventional UV filters absorb poorly at these wavelengths. Mexoryl 400 is the first commercially approved filter designed specifically for this range, and it has reshaped European and Asian formulation strategy since its 2007 EU approval. This explainer maps its absorption spectrum, documents the biology of the wavelengths it covers, and places it in context against the filters most readers already know.

Why the 380 to 400 Nanometer Band Causes Damage Conventional Filters Miss

Research published in the Journal of Investigative Dermatology by Marionnet and colleagues confirmed that long UVA wavelengths between 370 and 400nm penetrate deeper into the dermis than shorter UVA-II wavelengths and trigger oxidative stress markers that shorter UVA does not produce at equivalent doses. The damage profile differs from shorter UVA in three measurable ways.

Long UVA penetrates to a depth that affects dermal fibroblasts directly. UVB exhausts itself in the epidermis. UVA-II reaches the upper dermis. UVA-I extends further, and the 380–400nm portion reaches the deepest layer of the dermis where collagen and elastin synthesis occurs. Schalka and colleagues documented matrix metalloproteinase induction, particularly MMP-1 and MMP-3, at exposure levels that did not produce visible erythema. This is the molecular mechanism behind photoaging that develops without sunburn.

Pigmentary disorders show a particular sensitivity to this range. Persistent pigment darkening, the dermatology term for the slow tan that develops hours after exposure and lasts for days, is driven primarily by wavelengths above 380nm. Patients with melasma, post-inflammatory hyperpigmentation, and rosacea-associated dyschromia frequently report rebound darkening despite diligent sunscreen use. The explanation is often that their sunscreen does not absorb adequately past 380nm, leaving the dermal melanocytes exposed to the wavelengths that actually trigger the response.

Mitochondrial DNA damage was the third documented effect. Sklar and colleagues found that mitochondrial DNA in cultured fibroblasts accumulates oxidative lesions in proportion to ultra-long UVA dose, and unlike nuclear DNA, mitochondrial DNA lacks robust repair machinery. The damage is cumulative and contributes to long-term cellular dysfunction.

How Mexoryl 400's Stilbene Chromophore Absorbs at 385 Nanometers

The full INCI name, methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate, abbreviated MCE, describes a molecule built around a stilbene-derived chromophore. Stilbenes absorb strongly in the near-UV range, and the substituent groups attached to the stilbene core in this molecule shift the absorption peak to 385nm with meaningful absorbance extending to roughly 400nm. The maximum absorbance value reported by L'Oréal, which developed the filter, is approximately 32,000 L mol⁻¹ cm⁻¹ at peak, comparable to the molar extinction coefficients of the most efficient established filters.

The molecule is photostable, meaning its absorption profile does not degrade under sustained UV exposure. This is a meaningful contrast to avobenzone, which loses approximately 36% of its absorbance after one hour of sun exposure unless stabilized with octocrylene or a similar photostabilizer. Mexoryl 400 maintains its absorption capacity across an exposure window without requiring a stabilizer partner, which simplifies formulation and reduces the total filter load needed for sustained protection.

Solubility and texture are the formulator's other consideration. Mexoryl 400 is oil-soluble and disperses well in standard emollient bases, which is part of why L'Oréal-affiliated brands have integrated it into elegant lightweight fluids rather than the heavy creams that older filters often required. The absence of a photostabilizer requirement also frees up formula space for skin-supporting ingredients.

Spectrum Comparison Against the Filters You Already Know

Avobenzone, the most common UVA filter in US sunscreens, has a peak absorbance at 357nm and tapers significantly by 380nm. Bemotrizinol, often marketed as Tinosorb S, peaks near 310nm with a secondary peak at 345nm and substantial broad-spectrum coverage that extends but weakens past 370nm. Mexoryl SX peaks near 345nm and was designed specifically to cover UVA-II, not the longest UVA wavelengths. Titanium dioxide and zinc oxide cover broad ranges but with reduced efficiency past 370nm and visible whitening at the concentrations needed for high coverage.

Mexoryl 400 fills the 380–400nm portion of the spectrum that each of these filters covers weakly or not at all. The implication for formulators is that a modern broad-spectrum sunscreen targeting the full UVA range typically pairs Mexoryl 400 with bemotrizinol and a UVB filter such as octinoxate or octisalate. The combination produces a flat absorption curve from 290 to 400nm that single-filter and two-filter combinations cannot match.

Consumer-facing brands rarely communicate this layering strategy. La Roche-Posay's Anthelios UVMune 400, which introduced Mexoryl 400 to a broad European audience, pairs it with bemotrizinol, drometrizole trisiloxane (Mexoryl XL), and ethylhexyl triazone. Vichy's Capital Soleil UV-Age Daily uses a similar architecture. The result is a measured persistent pigment darkening protection factor, abbreviated PPD, that exceeds what avobenzone-based formulas can achieve at equivalent total filter percentage.

Global Approval Timeline and What US Consumers Should Know

The EU approved Mexoryl 400 in 2007, and Australia approved it in 2018. Most Asian markets that follow EU standards followed shortly after. The FDA has not approved Mexoryl 400 as of 2026, and the regulatory path remains slow because the agency still classifies most non-mineral filters under the GRASE framework that has not produced a new filter approval since 1999. The Sunscreen Innovation Act passed in 2014 was intended to accelerate this process but has not yet produced approvals for Mexoryl 400, bemotrizinol, or several other established European filters.

US consumers seeking ultra-long UVA protection have two practical options. The first is buying European or Asian sunscreens during travel or through retailers that legally import them for personal use. The second is selecting US-available formulas with the highest available UVA-PF rating, recognizing that the protection plateaus before reaching what Mexoryl 400 formulas deliver. Mineral sunscreens with high zinc oxide concentrations, typically 18% or above, provide the closest US-available coverage in the long UVA range, though with the visible whitening trade-off that limits cosmetic acceptability.

Reading labels remains the only reliable verification step. The INCI name methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate, sometimes abbreviated MCE on European labels, is the only confirmation that a formula contains Mexoryl 400. Marketing language about ultra-long UVA, 400nm protection, or next-generation filters is unregulated and used inconsistently across brands.

Frequently Asked Questions

What is the difference between Mexoryl 400 and Mexoryl SX?

Mexoryl SX, also known as ecamsule, is a sulfonic acid derivative with peak absorption near 345nm. Mexoryl 400 is a separate stilbene-based molecule with peak absorption at 385nm. They cover different portions of the UVA spectrum and are often layered in modern European formulas.

Is Mexoryl 400 approved in the United States?

Not as of 2026. The filter has been available in the EU since 2007 and Australia since 2018, but the FDA has not approved it for over-the-counter sunscreen use. Travelers can purchase it abroad for personal use.

Does Mexoryl 400 replace bemotrizinol or avobenzone?

No. The three filters cover different wavelength ranges and are most effective when combined. Bemotrizinol covers UVB and UVA-II, avobenzone covers UVA at 357nm peak, and Mexoryl 400 covers the 380–400nm gap. Modern formulas layer all three for flat-spectrum coverage.

Why does ultra-long UVA matter if SPF already protects me?

SPF measures UVB protection. Long UVA penetrates to the dermis and drives photoaging, persistent pigment darkening, and mitochondrial DNA damage that does not produce visible sunburn. Patients with melasma or post-inflammatory hyperpigmentation are particularly affected.

How can I tell if a sunscreen contains Mexoryl 400?

Check the INCI list for methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate, sometimes abbreviated MCE. Marketing claims are not regulated. The ingredient name on the label is the only reliable indicator.

What This Means for Your Routine

The practical step for readers in regions where Mexoryl 400 is approved is to verify the INCI list before assuming a sunscreen offers ultra-long UVA coverage. La Roche-Posay Anthelios UVMune 400 Invisible Fluid, Vichy Capital Soleil UV-Age Daily, and several Korean Beauty of Joseon and Anessa formulas contain it at meaningful concentrations. For US readers, the closest available approximation is a formula combining bemotrizinol, avobenzone with octocrylene stabilization, and a high-percentage zinc oxide, recognizing that the long UVA coverage plateau remains below what Mexoryl 400 formulas deliver. The next decade will determine whether the FDA's filter modernization proceeds; until then, label literacy is the only path to filling the 380–400nm gap.